Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cortical Spreading Depression | 71 | 2024 | 288 | 19.700 |
Why?
|
Migraine with Aura | 19 | 2022 | 204 | 4.510 |
Why?
|
Cerebrovascular Circulation | 49 | 2024 | 2725 | 4.400 |
Why?
|
Infarction, Middle Cerebral Artery | 21 | 2024 | 485 | 4.400 |
Why?
|
Brain Ischemia | 41 | 2024 | 3032 | 4.390 |
Why?
|
Migraine Disorders | 33 | 2023 | 1701 | 4.250 |
Why?
|
Stroke | 45 | 2024 | 9721 | 2.660 |
Why?
|
Subarachnoid Hemorrhage | 11 | 2023 | 1033 | 2.470 |
Why?
|
Hyperalgesia | 4 | 2024 | 526 | 2.230 |
Why?
|
Disease Models, Animal | 55 | 2024 | 18222 | 1.960 |
Why?
|
Vagus Nerve Stimulation | 6 | 2023 | 229 | 1.890 |
Why?
|
rho-Associated Kinases | 5 | 2024 | 281 | 1.720 |
Why?
|
Cerebral Cortex | 22 | 2023 | 5775 | 1.610 |
Why?
|
CADASIL | 4 | 2022 | 82 | 1.530 |
Why?
|
Mice, Inbred C57BL | 51 | 2024 | 22128 | 1.410 |
Why?
|
Animals | 160 | 2024 | 168089 | 1.410 |
Why?
|
Mice, Transgenic | 14 | 2024 | 9520 | 1.400 |
Why?
|
Calcium Channels, N-Type | 6 | 2015 | 42 | 1.390 |
Why?
|
Mice | 104 | 2024 | 81330 | 1.370 |
Why?
|
Headache | 7 | 2024 | 1255 | 1.270 |
Why?
|
Cerebral Infarction | 8 | 2020 | 981 | 1.190 |
Why?
|
Arterioles | 9 | 2021 | 250 | 1.140 |
Why?
|
Endothelin-1 | 6 | 2020 | 302 | 1.030 |
Why?
|
Rats, Sprague-Dawley | 31 | 2023 | 8164 | 1.010 |
Why?
|
Somatosensory Cortex | 5 | 2019 | 512 | 0.990 |
Why?
|
Oxygen | 11 | 2019 | 4228 | 0.980 |
Why?
|
Brain | 36 | 2023 | 27094 | 0.970 |
Why?
|
Rats | 43 | 2024 | 23705 | 0.970 |
Why?
|
Aneurysm, Ruptured | 2 | 2020 | 464 | 0.940 |
Why?
|
Blood-Brain Barrier | 6 | 2024 | 1028 | 0.930 |
Why?
|
Cerebrovascular Disorders | 5 | 2015 | 1474 | 0.860 |
Why?
|
Vasospasm, Intracranial | 2 | 2020 | 214 | 0.830 |
Why?
|
Cerebral Hemorrhage | 5 | 2023 | 2642 | 0.820 |
Why?
|
Vasodilation | 5 | 2020 | 966 | 0.820 |
Why?
|
NAD | 3 | 2023 | 612 | 0.780 |
Why?
|
Leukoaraiosis | 1 | 2022 | 116 | 0.740 |
Why?
|
Gene Knock-In Techniques | 4 | 2021 | 420 | 0.720 |
Why?
|
Laser-Doppler Flowmetry | 16 | 2018 | 239 | 0.710 |
Why?
|
Oxytocin | 1 | 2024 | 402 | 0.700 |
Why?
|
Regional Blood Flow | 6 | 2018 | 1498 | 0.690 |
Why?
|
Hypoxia, Brain | 4 | 2018 | 139 | 0.690 |
Why?
|
Hyperoxia | 3 | 2014 | 259 | 0.690 |
Why?
|
Neurons | 16 | 2024 | 9429 | 0.690 |
Why?
|
Intracranial Aneurysm | 2 | 2020 | 1286 | 0.680 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2011 | 140 | 0.680 |
Why?
|
Seizures | 2 | 2024 | 2965 | 0.670 |
Why?
|
Anticonvulsants | 4 | 2017 | 1910 | 0.670 |
Why?
|
Receptors, Notch | 6 | 2022 | 743 | 0.670 |
Why?
|
Anesthetics | 3 | 2019 | 523 | 0.660 |
Why?
|
Brain Injuries | 11 | 2024 | 2054 | 0.650 |
Why?
|
Amines | 2 | 2011 | 280 | 0.640 |
Why?
|
Maze Learning | 4 | 2020 | 481 | 0.630 |
Why?
|
Male | 108 | 2024 | 360703 | 0.620 |
Why?
|
Cerebral Arteries | 4 | 2019 | 490 | 0.620 |
Why?
|
Transcytosis | 1 | 2018 | 45 | 0.620 |
Why?
|
Hyperlipidemias | 2 | 2013 | 771 | 0.610 |
Why?
|
Capillaries | 2 | 2021 | 755 | 0.600 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 49 | 0.570 |
Why?
|
Tomography, Optical Coherence | 5 | 2021 | 2923 | 0.550 |
Why?
|
Caveolin 1 | 1 | 2018 | 255 | 0.550 |
Why?
|
Behavior, Animal | 4 | 2020 | 1873 | 0.550 |
Why?
|
Oxygen Consumption | 5 | 2014 | 1867 | 0.540 |
Why?
|
Hippocampus | 6 | 2024 | 3754 | 0.540 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2013 | 56 | 0.520 |
Why?
|
Hypotension | 3 | 2012 | 879 | 0.520 |
Why?
|
Endothelium | 1 | 2018 | 763 | 0.510 |
Why?
|
Arteries | 2 | 2020 | 1121 | 0.510 |
Why?
|
Pericytes | 1 | 2018 | 295 | 0.510 |
Why?
|
Nitric Oxide Synthase | 11 | 2004 | 909 | 0.500 |
Why?
|
Ischemic Attack, Transient | 7 | 2023 | 874 | 0.500 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2016 | 858 | 0.480 |
Why?
|
Membrane Potentials | 3 | 2015 | 1088 | 0.470 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2011 | 1139 | 0.460 |
Why?
|
CA1 Region, Hippocampal | 1 | 2015 | 109 | 0.460 |
Why?
|
N-Methylaspartate | 5 | 2005 | 230 | 0.460 |
Why?
|
Sodium, Dietary | 1 | 2018 | 425 | 0.460 |
Why?
|
Internal Capsule | 1 | 2015 | 138 | 0.450 |
Why?
|
Neuroprotective Agents | 6 | 2016 | 956 | 0.440 |
Why?
|
Vibrissae | 5 | 2019 | 116 | 0.440 |
Why?
|
Potassium Chloride | 5 | 2011 | 229 | 0.430 |
Why?
|
Long-Term Potentiation | 1 | 2015 | 290 | 0.430 |
Why?
|
Analgesics | 4 | 2022 | 1068 | 0.430 |
Why?
|
Depression | 3 | 2023 | 8132 | 0.420 |
Why?
|
Excitatory Amino Acid Antagonists | 4 | 2020 | 446 | 0.420 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2021 | 893 | 0.420 |
Why?
|
Triazines | 1 | 2014 | 311 | 0.410 |
Why?
|
Fructose | 1 | 2014 | 285 | 0.410 |
Why?
|
Visual Cortex | 1 | 2020 | 1104 | 0.410 |
Why?
|
Hyperemia | 5 | 2019 | 225 | 0.410 |
Why?
|
Models, Neurological | 5 | 2020 | 1769 | 0.410 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1385 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 18 | 2024 | 36415 | 0.400 |
Why?
|
Conditioning, Classical | 1 | 2015 | 367 | 0.400 |
Why?
|
Wakefulness | 1 | 2019 | 1264 | 0.400 |
Why?
|
Motor Skills | 1 | 2015 | 521 | 0.390 |
Why?
|
Motor Cortex | 1 | 2019 | 1006 | 0.380 |
Why?
|
Corpus Callosum | 4 | 2022 | 750 | 0.380 |
Why?
|
Thalamus | 2 | 2015 | 1046 | 0.370 |
Why?
|
Endothelium, Vascular | 6 | 2019 | 4420 | 0.370 |
Why?
|
Carbamazepine | 2 | 2010 | 224 | 0.370 |
Why?
|
Electric Stimulation | 8 | 2019 | 1736 | 0.370 |
Why?
|
Vasoconstrictor Agents | 2 | 2019 | 655 | 0.360 |
Why?
|
Reperfusion Injury | 5 | 2019 | 1026 | 0.350 |
Why?
|
Pancreatic Elastase | 2 | 2020 | 126 | 0.340 |
Why?
|
Mice, Knockout | 24 | 2020 | 14392 | 0.330 |
Why?
|
Neurotransmitter Agents | 3 | 2017 | 664 | 0.330 |
Why?
|
Estrogens | 2 | 2023 | 1522 | 0.330 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2016 | 411 | 0.320 |
Why?
|
Enzyme Inhibitors | 8 | 2017 | 3702 | 0.320 |
Why?
|
Pia Mater | 3 | 2005 | 87 | 0.320 |
Why?
|
Progesterone | 2 | 2023 | 742 | 0.320 |
Why?
|
Perfusion | 3 | 2018 | 1390 | 0.310 |
Why?
|
Vasoconstriction | 4 | 2019 | 592 | 0.310 |
Why?
|
Recovery of Function | 6 | 2022 | 2981 | 0.310 |
Why?
|
Brain Infarction | 3 | 2024 | 289 | 0.310 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 691 | 0.300 |
Why?
|
Blood Vessels | 2 | 2013 | 1111 | 0.300 |
Why?
|
Nitroarginine | 7 | 2004 | 66 | 0.290 |
Why?
|
Physical Stimulation | 4 | 2019 | 517 | 0.290 |
Why?
|
Paresis | 1 | 2008 | 176 | 0.290 |
Why?
|
Blood Volume | 5 | 2018 | 547 | 0.290 |
Why?
|
Hemorrhage | 1 | 2019 | 3422 | 0.280 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 3 | 2015 | 267 | 0.280 |
Why?
|
Neural Pathways | 3 | 2015 | 3056 | 0.270 |
Why?
|
Humans | 84 | 2024 | 761222 | 0.270 |
Why?
|
Evoked Potentials | 4 | 2019 | 1047 | 0.270 |
Why?
|
Potassium | 4 | 2022 | 1309 | 0.270 |
Why?
|
Brain Edema | 5 | 2014 | 604 | 0.270 |
Why?
|
Mutation, Missense | 2 | 2015 | 2567 | 0.270 |
Why?
|
Calcium | 2 | 2019 | 5719 | 0.260 |
Why?
|
Stress, Psychological | 2 | 2019 | 4487 | 0.260 |
Why?
|
Inflammation | 5 | 2019 | 10759 | 0.260 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2223 | 0.260 |
Why?
|
Simvastatin | 1 | 2008 | 346 | 0.260 |
Why?
|
Nitric Oxide Synthase Type III | 5 | 2014 | 705 | 0.260 |
Why?
|
Random Allocation | 3 | 2019 | 2393 | 0.260 |
Why?
|
Synapses | 1 | 2015 | 1755 | 0.250 |
Why?
|
Anxiety | 1 | 2020 | 4569 | 0.250 |
Why?
|
Nerve Net | 2 | 2018 | 2288 | 0.250 |
Why?
|
Blood Pressure | 11 | 2019 | 8479 | 0.250 |
Why?
|
Hypoglycemia | 1 | 2012 | 883 | 0.240 |
Why?
|
Cerebellar Ataxia | 3 | 2018 | 150 | 0.240 |
Why?
|
Foramen Ovale, Patent | 2 | 2022 | 208 | 0.240 |
Why?
|
Cerebellar Cortex | 1 | 2005 | 107 | 0.240 |
Why?
|
Supraoptic Nucleus | 1 | 2024 | 28 | 0.240 |
Why?
|
Sulfonic Acids | 2 | 2015 | 102 | 0.230 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2024 | 113 | 0.230 |
Why?
|
Receptors, Oxytocin | 1 | 2024 | 69 | 0.230 |
Why?
|
Female | 39 | 2024 | 392552 | 0.230 |
Why?
|
Point Mutation | 1 | 2009 | 1593 | 0.230 |
Why?
|
Neuroglia | 1 | 2010 | 953 | 0.230 |
Why?
|
Homeostasis | 5 | 2022 | 3322 | 0.220 |
Why?
|
Hyperglycemia | 1 | 2012 | 1375 | 0.220 |
Why?
|
Estrus | 1 | 2023 | 70 | 0.220 |
Why?
|
Mutation | 8 | 2022 | 30004 | 0.220 |
Why?
|
Glucose | 4 | 2018 | 4342 | 0.220 |
Why?
|
Kainic Acid | 2 | 2021 | 203 | 0.220 |
Why?
|
Calcium Channels | 4 | 2010 | 620 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 2 | 2024 | 5665 | 0.210 |
Why?
|
Rheology | 1 | 2004 | 347 | 0.210 |
Why?
|
Intracranial Pressure | 2 | 2022 | 324 | 0.210 |
Why?
|
Mefenamic Acid | 1 | 2022 | 5 | 0.200 |
Why?
|
Research Design | 3 | 2023 | 6180 | 0.200 |
Why?
|
Thrombectomy | 2 | 2017 | 703 | 0.200 |
Why?
|
Piperazines | 2 | 2024 | 2522 | 0.200 |
Why?
|
Glutamates | 1 | 2023 | 385 | 0.200 |
Why?
|
Hemodynamics | 5 | 2023 | 4165 | 0.190 |
Why?
|
Models, Genetic | 1 | 2012 | 3430 | 0.190 |
Why?
|
Bicuculline | 1 | 2021 | 96 | 0.190 |
Why?
|
Microcirculation | 3 | 2023 | 1280 | 0.190 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2019 | 1488 | 0.190 |
Why?
|
Blood Glucose | 2 | 2012 | 6392 | 0.180 |
Why?
|
Desoxycorticosterone | 1 | 2020 | 46 | 0.180 |
Why?
|
4-Aminopyridine | 1 | 2021 | 80 | 0.180 |
Why?
|
Rotarod Performance Test | 1 | 2020 | 63 | 0.180 |
Why?
|
Receptors, GABA-A | 2 | 2023 | 621 | 0.180 |
Why?
|
Tetrodotoxin | 2 | 2021 | 245 | 0.180 |
Why?
|
Potassium Channel Blockers | 1 | 2021 | 161 | 0.180 |
Why?
|
Leukoencephalopathies | 2 | 2014 | 257 | 0.180 |
Why?
|
Electrophysiology | 4 | 2010 | 1262 | 0.180 |
Why?
|
Dipeptides | 2 | 2020 | 386 | 0.180 |
Why?
|
Calcium Channels, P-Type | 1 | 2000 | 9 | 0.180 |
Why?
|
Hematoma | 2 | 2023 | 763 | 0.170 |
Why?
|
Brain Concussion | 3 | 2018 | 1404 | 0.170 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2019 | 17 | 0.170 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 363 | 0.170 |
Why?
|
Middle Cerebral Artery | 3 | 2019 | 275 | 0.170 |
Why?
|
Migraine without Aura | 1 | 2020 | 82 | 0.170 |
Why?
|
Pain Threshold | 1 | 2023 | 603 | 0.160 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2019 | 189 | 0.160 |
Why?
|
Neovascularization, Physiologic | 2 | 2018 | 1347 | 0.160 |
Why?
|
Testosterone | 1 | 2009 | 2472 | 0.160 |
Why?
|
Cluster Headache | 1 | 2019 | 54 | 0.160 |
Why?
|
Ischemia | 3 | 2023 | 1889 | 0.150 |
Why?
|
Acute Disease | 3 | 2019 | 7226 | 0.150 |
Why?
|
Electroencephalography | 6 | 2020 | 6242 | 0.150 |
Why?
|
Apolipoproteins E | 2 | 2014 | 1443 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 5 | 2019 | 17897 | 0.150 |
Why?
|
Endothelins | 1 | 2018 | 127 | 0.150 |
Why?
|
Rats, Inbred SHR | 1 | 2018 | 186 | 0.150 |
Why?
|
Penicillins | 1 | 2021 | 403 | 0.150 |
Why?
|
Ligation | 2 | 2018 | 446 | 0.150 |
Why?
|
Hypercapnia | 3 | 2007 | 259 | 0.150 |
Why?
|
Nervous System | 1 | 2021 | 545 | 0.150 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2020 | 323 | 0.150 |
Why?
|
Free Radicals | 1 | 2018 | 238 | 0.150 |
Why?
|
Neuromuscular Nondepolarizing Agents | 2 | 2015 | 143 | 0.150 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2017 | 24 | 0.140 |
Why?
|
Vagus Nerve | 1 | 2020 | 458 | 0.140 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2020 | 269 | 0.140 |
Why?
|
Monitoring, Physiologic | 3 | 2018 | 1780 | 0.140 |
Why?
|
Carotid Artery, Common | 1 | 2018 | 175 | 0.140 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12676 | 0.140 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2017 | 86 | 0.140 |
Why?
|
Critical Care | 2 | 2016 | 2696 | 0.140 |
Why?
|
Excitatory Amino Acid Agonists | 4 | 2005 | 142 | 0.140 |
Why?
|
Injections | 1 | 2020 | 832 | 0.140 |
Why?
|
Mice, Neurologic Mutants | 2 | 2011 | 107 | 0.140 |
Why?
|
Sodium Chloride, Dietary | 1 | 2019 | 292 | 0.140 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2019 | 698 | 0.140 |
Why?
|
Animals, Genetically Modified | 2 | 2012 | 1559 | 0.130 |
Why?
|
Thrombotic Microangiopathies | 1 | 2018 | 123 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2871 | 0.130 |
Why?
|
Estradiol | 1 | 2023 | 1937 | 0.130 |
Why?
|
gamma-Cyclodextrins | 1 | 2015 | 17 | 0.130 |
Why?
|
Aconitine | 1 | 1995 | 3 | 0.130 |
Why?
|
Sex Factors | 3 | 2020 | 10553 | 0.130 |
Why?
|
Tight Junctions | 1 | 2018 | 324 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2016 | 2787 | 0.130 |
Why?
|
Brain Stem | 1 | 2021 | 858 | 0.130 |
Why?
|
Hydroquinones | 1 | 2015 | 34 | 0.130 |
Why?
|
Calcium-Transporting ATPases | 1 | 2015 | 122 | 0.120 |
Why?
|
Disease Susceptibility | 3 | 2011 | 1791 | 0.120 |
Why?
|
Glutamic Acid | 3 | 2022 | 1173 | 0.120 |
Why?
|
Connexins | 1 | 2017 | 352 | 0.120 |
Why?
|
Astrocytes | 2 | 2015 | 1341 | 0.120 |
Why?
|
Dogs | 1 | 2020 | 3832 | 0.120 |
Why?
|
Long-Term Synaptic Depression | 1 | 2015 | 59 | 0.120 |
Why?
|
Aging | 3 | 2023 | 8702 | 0.120 |
Why?
|
Deferoxamine | 1 | 2015 | 155 | 0.120 |
Why?
|
Acetylcholine | 3 | 2006 | 629 | 0.120 |
Why?
|
Light | 2 | 2018 | 1348 | 0.120 |
Why?
|
Brain Mapping | 3 | 2019 | 6635 | 0.120 |
Why?
|
Sirtuin 2 | 1 | 2015 | 94 | 0.120 |
Why?
|
Iron Chelating Agents | 1 | 2015 | 141 | 0.110 |
Why?
|
Benzylisoquinolines | 1 | 2013 | 15 | 0.110 |
Why?
|
Quinazolines | 1 | 2020 | 1371 | 0.110 |
Why?
|
Corticosterone | 1 | 2014 | 301 | 0.110 |
Why?
|
Propylene Glycols | 1 | 2014 | 91 | 0.110 |
Why?
|
Myelin Sheath | 2 | 2015 | 653 | 0.110 |
Why?
|
DNA Glycosylases | 1 | 2014 | 124 | 0.110 |
Why?
|
Hypertension | 2 | 2018 | 8536 | 0.110 |
Why?
|
Rabbits | 1 | 2020 | 4750 | 0.110 |
Why?
|
Hepatocyte Growth Factor | 1 | 2015 | 270 | 0.110 |
Why?
|
Phenotype | 4 | 2023 | 16575 | 0.110 |
Why?
|
Caffeine | 1 | 2018 | 701 | 0.110 |
Why?
|
Sleep Deprivation | 1 | 2020 | 847 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1988 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3245 | 0.110 |
Why?
|
Thrombolytic Therapy | 2 | 2024 | 2055 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2018 | 803 | 0.110 |
Why?
|
Rest | 1 | 2018 | 920 | 0.100 |
Why?
|
Neuromuscular Junction | 1 | 1995 | 405 | 0.100 |
Why?
|
Nitrous Oxide | 2 | 2016 | 166 | 0.100 |
Why?
|
Anesthesia | 2 | 2016 | 1591 | 0.100 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2013 | 129 | 0.100 |
Why?
|
Cerebral Angiography | 2 | 2019 | 1281 | 0.100 |
Why?
|
Chemoprevention | 1 | 2014 | 325 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1331 | 0.100 |
Why?
|
Valproic Acid | 2 | 2010 | 443 | 0.100 |
Why?
|
Research | 2 | 2018 | 1976 | 0.100 |
Why?
|
Environment | 1 | 2018 | 1122 | 0.100 |
Why?
|
Colon | 1 | 2020 | 1791 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2015 | 10756 | 0.100 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.100 |
Why?
|
Sphingosine | 1 | 2014 | 307 | 0.100 |
Why?
|
Cell Death | 5 | 2019 | 1676 | 0.100 |
Why?
|
Isoenzymes | 1 | 1996 | 1682 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1234 | 0.090 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4404 | 0.090 |
Why?
|
Corpus Striatum | 1 | 1997 | 1234 | 0.090 |
Why?
|
Oxyhemoglobins | 2 | 2011 | 212 | 0.090 |
Why?
|
Case-Control Studies | 3 | 2020 | 22174 | 0.090 |
Why?
|
Receptors, Purinergic | 1 | 2011 | 66 | 0.090 |
Why?
|
Cell Survival | 2 | 2019 | 5778 | 0.090 |
Why?
|
Energy Metabolism | 2 | 2015 | 2877 | 0.090 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2005 | 894 | 0.090 |
Why?
|
Warfarin | 1 | 2019 | 1482 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1663 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2024 | 2181 | 0.090 |
Why?
|
Isoflurane | 2 | 2008 | 384 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 2 | 2007 | 1162 | 0.090 |
Why?
|
Injections, Intravenous | 2 | 2010 | 1376 | 0.090 |
Why?
|
Signal Transduction | 6 | 2019 | 23419 | 0.090 |
Why?
|
Airway Remodeling | 1 | 2011 | 132 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2023 | 3410 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2802 | 0.080 |
Why?
|
Models, Animal | 1 | 2016 | 2114 | 0.080 |
Why?
|
Rodentia | 2 | 2023 | 261 | 0.080 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2011 | 241 | 0.080 |
Why?
|
Guanylate Cyclase | 1 | 2010 | 205 | 0.080 |
Why?
|
Respiratory Hypersensitivity | 1 | 2011 | 271 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 731 | 0.080 |
Why?
|
Ions | 1 | 2010 | 255 | 0.080 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 306 | 0.080 |
Why?
|
Neural Stem Cells | 2 | 2013 | 886 | 0.080 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1375 | 0.080 |
Why?
|
Benzamides | 1 | 2015 | 1371 | 0.080 |
Why?
|
Swine | 1 | 2019 | 5909 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3031 | 0.080 |
Why?
|
Oligodendroglia | 1 | 2013 | 537 | 0.080 |
Why?
|
Chloralose | 1 | 2008 | 14 | 0.080 |
Why?
|
Hot Temperature | 1 | 2015 | 1434 | 0.080 |
Why?
|
Urethane | 1 | 2008 | 36 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2872 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2011 | 582 | 0.080 |
Why?
|
Time Factors | 6 | 2018 | 39957 | 0.080 |
Why?
|
Sodium Channels | 1 | 2010 | 339 | 0.080 |
Why?
|
Action Potentials | 1 | 2016 | 1830 | 0.080 |
Why?
|
Cell Communication | 1 | 2015 | 1651 | 0.070 |
Why?
|
Oxidative Phosphorylation | 1 | 2010 | 495 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2007 | 517 | 0.070 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 476 | 0.070 |
Why?
|
Orchiectomy | 1 | 2009 | 463 | 0.070 |
Why?
|
Phenylephrine | 1 | 2008 | 294 | 0.070 |
Why?
|
Plaque, Amyloid | 1 | 2011 | 762 | 0.070 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2008 | 198 | 0.070 |
Why?
|
Coma | 1 | 2011 | 484 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2293 | 0.070 |
Why?
|
Rats, Wistar | 3 | 2015 | 1848 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3304 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2864 | 0.070 |
Why?
|
Neurogenesis | 1 | 2013 | 862 | 0.070 |
Why?
|
Axons | 1 | 2015 | 1671 | 0.070 |
Why?
|
Stimulation, Chemical | 1 | 2006 | 306 | 0.070 |
Why?
|
Memory Disorders | 1 | 2014 | 1198 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4373 | 0.070 |
Why?
|
Embolism | 1 | 2010 | 399 | 0.070 |
Why?
|
Ovariectomy | 1 | 2008 | 614 | 0.070 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2006 | 260 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2092 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1760 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12728 | 0.070 |
Why?
|
Spectrum Analysis | 1 | 2008 | 449 | 0.070 |
Why?
|
Amyloid beta-Peptides | 2 | 2011 | 3841 | 0.070 |
Why?
|
Fear | 1 | 2015 | 1477 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2008 | 710 | 0.060 |
Why?
|
Dietary Fats | 1 | 2013 | 1994 | 0.060 |
Why?
|
Glycolysis | 1 | 2010 | 836 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6223 | 0.060 |
Why?
|
Myasthenia Gravis | 1 | 2008 | 214 | 0.060 |
Why?
|
Calcium Signaling | 1 | 2010 | 731 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2041 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2893 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1977 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5755 | 0.060 |
Why?
|
Atracurium | 2 | 2015 | 51 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2217 | 0.060 |
Why?
|
Androstanols | 2 | 2015 | 45 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2019 | 64681 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2008 | 602 | 0.060 |
Why?
|
Phosphorylation | 2 | 2013 | 8300 | 0.060 |
Why?
|
Neural Inhibition | 1 | 2008 | 586 | 0.060 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2015 | 1462 | 0.060 |
Why?
|
Drug Design | 1 | 2008 | 1044 | 0.050 |
Why?
|
Anticoagulants | 1 | 2019 | 4795 | 0.050 |
Why?
|
Middle Aged | 13 | 2020 | 220858 | 0.050 |
Why?
|
Thymus Gland | 1 | 2008 | 1243 | 0.050 |
Why?
|
Liver | 2 | 2019 | 7512 | 0.050 |
Why?
|
Sympathetic Nervous System | 1 | 2006 | 519 | 0.050 |
Why?
|
Adult | 13 | 2020 | 221120 | 0.050 |
Why?
|
Fibrinolysis | 1 | 2004 | 332 | 0.050 |
Why?
|
Caspase 3 | 3 | 2016 | 730 | 0.050 |
Why?
|
Intracranial Embolism | 1 | 2004 | 189 | 0.050 |
Why?
|
Dementia | 1 | 2017 | 2684 | 0.050 |
Why?
|
Prospective Studies | 3 | 2024 | 54437 | 0.050 |
Why?
|
Infarction | 1 | 2024 | 248 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 80675 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18384 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2006 | 989 | 0.050 |
Why?
|
Drug Discovery | 1 | 2010 | 1048 | 0.050 |
Why?
|
Aged | 10 | 2022 | 169292 | 0.050 |
Why?
|
Reperfusion | 4 | 2010 | 271 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2082 | 0.050 |
Why?
|
Tryptamines | 1 | 2022 | 93 | 0.050 |
Why?
|
Drug Interactions | 1 | 2006 | 1417 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2022 | 150 | 0.050 |
Why?
|
Neurologic Examination | 2 | 2018 | 915 | 0.050 |
Why?
|
Hemoglobins | 1 | 2007 | 1525 | 0.050 |
Why?
|
Troponin T | 1 | 2006 | 780 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2015 | 2867 | 0.040 |
Why?
|
Extracellular Space | 2 | 2019 | 563 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2020 | 12341 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2011 | 2640 | 0.040 |
Why?
|
Hepatocytes | 2 | 2019 | 1230 | 0.040 |
Why?
|
Iontophoresis | 2 | 1997 | 74 | 0.040 |
Why?
|
Diethylnitrosamine | 1 | 2019 | 45 | 0.040 |
Why?
|
Differential Threshold | 1 | 2000 | 80 | 0.040 |
Why?
|
Lasers | 1 | 2004 | 952 | 0.040 |
Why?
|
Alleles | 1 | 2011 | 6857 | 0.040 |
Why?
|
Receptors, Glutamate | 2 | 1997 | 227 | 0.040 |
Why?
|
Physical Examination | 1 | 2006 | 1255 | 0.040 |
Why?
|
Laboratories | 1 | 2023 | 462 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4111 | 0.040 |
Why?
|
Venules | 1 | 2019 | 161 | 0.040 |
Why?
|
Genotype | 2 | 2011 | 12985 | 0.040 |
Why?
|
Vasculitis | 1 | 2003 | 522 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2916 | 0.040 |
Why?
|
Forelimb | 3 | 2009 | 116 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7033 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 2020 | 258 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 658 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 754 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1428 | 0.040 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2018 | 161 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2019 | 18927 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4851 | 0.040 |
Why?
|
Spin Labels | 1 | 2019 | 337 | 0.040 |
Why?
|
Angiography | 2 | 2015 | 1597 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11067 | 0.040 |
Why?
|
Insulin | 1 | 2012 | 6588 | 0.040 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1997 | 70 | 0.040 |
Why?
|
Functional Laterality | 2 | 2018 | 2257 | 0.040 |
Why?
|
Cognition | 3 | 2023 | 6988 | 0.040 |
Why?
|
Hydroxyl Radical | 1 | 1997 | 82 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
DNA Damage | 2 | 2019 | 2443 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 1997 | 172 | 0.040 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 1999 | 247 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 1997 | 237 | 0.040 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2013 | 631 | 0.040 |
Why?
|
Apoptosis | 3 | 2020 | 9478 | 0.030 |
Why?
|
Nitric Oxide | 3 | 2010 | 2137 | 0.030 |
Why?
|
History, 19th Century | 1 | 2019 | 718 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2019 | 823 | 0.030 |
Why?
|
Cyclic GMP | 1 | 1998 | 395 | 0.030 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 188 | 0.030 |
Why?
|
Mitochondria | 1 | 2010 | 3620 | 0.030 |
Why?
|
Radio Waves | 1 | 2018 | 251 | 0.030 |
Why?
|
Arginine | 2 | 1998 | 920 | 0.030 |
Why?
|
Vecuronium Bromide | 1 | 2015 | 33 | 0.030 |
Why?
|
Fever | 1 | 2004 | 1618 | 0.030 |
Why?
|
Goblet Cells | 1 | 2019 | 298 | 0.030 |
Why?
|
Dihydropyridines | 1 | 1996 | 67 | 0.030 |
Why?
|
Ischemic Preconditioning | 1 | 2016 | 89 | 0.030 |
Why?
|
Neurotoxins | 1 | 1997 | 240 | 0.030 |
Why?
|
Microelectrodes | 1 | 1997 | 306 | 0.030 |
Why?
|
Neuritis | 1 | 1995 | 35 | 0.030 |
Why?
|
Neostigmine | 1 | 2015 | 68 | 0.030 |
Why?
|
GABA Agents | 1 | 1995 | 41 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2017 | 6586 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2018 | 656 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2018 | 3770 | 0.030 |
Why?
|
Spinal Cord | 1 | 2003 | 1807 | 0.030 |
Why?
|
Models, Biological | 2 | 2010 | 9458 | 0.030 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2015 | 89 | 0.030 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 1995 | 101 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2000 | 1695 | 0.030 |
Why?
|
Pilot Projects | 1 | 2008 | 8642 | 0.030 |
Why?
|
Reactive Nitrogen Species | 1 | 2014 | 34 | 0.030 |
Why?
|
Carbocyanines | 1 | 2015 | 175 | 0.030 |
Why?
|
Pain | 1 | 2010 | 5072 | 0.030 |
Why?
|
Serum Albumin, Bovine | 1 | 1995 | 319 | 0.030 |
Why?
|
Risk Factors | 3 | 2019 | 74241 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2022 | 5250 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 1141 | 0.030 |
Why?
|
Time | 1 | 2016 | 545 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 412 | 0.030 |
Why?
|
Trigeminal Ganglion | 1 | 1995 | 186 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15637 | 0.030 |
Why?
|
Head Injuries, Closed | 1 | 2015 | 133 | 0.030 |
Why?
|
Substance P | 1 | 1995 | 334 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 551 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2014 | 452 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2015 | 380 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 379 | 0.030 |
Why?
|
Antimutagenic Agents | 1 | 2013 | 6 | 0.030 |
Why?
|
Ketamine | 1 | 2020 | 517 | 0.030 |
Why?
|
Caspases | 1 | 1997 | 878 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2006 | 2021 | 0.030 |
Why?
|
Dura Mater | 1 | 1995 | 290 | 0.030 |
Why?
|
Matrix Metalloproteinases, Secreted | 1 | 2013 | 13 | 0.030 |
Why?
|
Macrocyclic Compounds | 1 | 2013 | 68 | 0.030 |
Why?
|
HMGB1 Protein | 1 | 2014 | 136 | 0.030 |
Why?
|
Cobalt | 1 | 2013 | 148 | 0.030 |
Why?
|
Tyrosine | 1 | 1997 | 1422 | 0.030 |
Why?
|
Autoradiography | 3 | 1999 | 730 | 0.030 |
Why?
|
Myocardium | 1 | 2006 | 4746 | 0.030 |
Why?
|
History, 21st Century | 1 | 2019 | 1567 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2014 | 303 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 426 | 0.030 |
Why?
|
Reference Values | 1 | 2000 | 4921 | 0.030 |
Why?
|
Algorithms | 3 | 2011 | 14025 | 0.030 |
Why?
|
Lung | 1 | 2011 | 9979 | 0.030 |
Why?
|
Tissue Distribution | 3 | 2004 | 2263 | 0.020 |
Why?
|
Neuromuscular Blockade | 1 | 2013 | 147 | 0.020 |
Why?
|
Consensus | 1 | 2022 | 3134 | 0.020 |
Why?
|
Amyloid | 1 | 2017 | 848 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2270 | 0.020 |
Why?
|
Insulysin | 1 | 2011 | 49 | 0.020 |
Why?
|
Anesthetics, Inhalation | 1 | 1997 | 573 | 0.020 |
Why?
|
Capillary Permeability | 1 | 1995 | 773 | 0.020 |
Why?
|
Alum Compounds | 1 | 2011 | 32 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9319 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2013 | 490 | 0.020 |
Why?
|
History, 20th Century | 1 | 2019 | 2765 | 0.020 |
Why?
|
Optical Phenomena | 1 | 2011 | 106 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 501 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2013 | 221 | 0.020 |
Why?
|
Meclizine | 1 | 2010 | 13 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29688 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 390 | 0.020 |
Why?
|
Nanostructures | 1 | 2015 | 551 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 904 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1187 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20118 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2570 | 0.020 |
Why?
|
Ovalbumin | 1 | 2011 | 671 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2013 | 752 | 0.020 |
Why?
|
Partial Pressure | 1 | 2009 | 245 | 0.020 |
Why?
|
Thymus Extracts | 1 | 2008 | 2 | 0.020 |
Why?
|
Galactose | 1 | 2010 | 294 | 0.020 |
Why?
|
Neprilysin | 1 | 2011 | 478 | 0.020 |
Why?
|
Binding Sites | 1 | 1997 | 5988 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3606 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2452 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58952 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15545 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14675 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2015 | 742 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6200 | 0.020 |
Why?
|
Attention | 1 | 2018 | 2394 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15308 | 0.020 |
Why?
|
Carotid Stenosis | 1 | 2015 | 859 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1920 | 0.020 |
Why?
|
Presenilin-1 | 1 | 2011 | 660 | 0.020 |
Why?
|
Transgenes | 1 | 2011 | 1008 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2008 | 5871 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2007 | 126 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2009 | 340 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3803 | 0.020 |
Why?
|
Crohn Disease | 1 | 2020 | 2278 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2723 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6781 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 580 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3671 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 3044 | 0.020 |
Why?
|
Iodine Radioisotopes | 2 | 2004 | 1030 | 0.020 |
Why?
|
Keratins | 1 | 2008 | 498 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2138 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 613 | 0.020 |
Why?
|
Systems Integration | 1 | 2008 | 428 | 0.020 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2011 | 1111 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1256 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22142 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2636 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2008 | 628 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2413 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3727 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2007 | 550 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2007 | 459 | 0.020 |
Why?
|
Heart Rate | 2 | 2013 | 4197 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2018 | 3552 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 574 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9187 | 0.010 |
Why?
|
Equipment Design | 1 | 2013 | 3510 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2854 | 0.010 |
Why?
|
Alanine | 1 | 2007 | 608 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2004 | 181 | 0.010 |
Why?
|
Shivering | 1 | 2004 | 12 | 0.010 |
Why?
|
Tail | 1 | 2004 | 90 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10423 | 0.010 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2003 | 71 | 0.010 |
Why?
|
Brain Damage, Chronic | 1 | 2004 | 266 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1901 | 0.010 |
Why?
|
Serine | 1 | 2007 | 826 | 0.010 |
Why?
|
Vascular Resistance | 2 | 1996 | 933 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59222 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3571 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10516 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8002 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1168 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2680 | 0.010 |
Why?
|
Cell Separation | 1 | 2008 | 1721 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2014 | 1923 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14610 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2006 | 1577 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5969 | 0.010 |
Why?
|
Electric Impedance | 2 | 1997 | 756 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11855 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2004 | 580 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1610 | 0.010 |
Why?
|
Fibrin | 1 | 2004 | 507 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 2004 | 445 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 88300 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1838 | 0.010 |
Why?
|
Observer Variation | 1 | 2007 | 2610 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13367 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2006 | 852 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2003 | 544 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1995 | 4947 | 0.010 |
Why?
|
Aorta | 1 | 2008 | 2040 | 0.010 |
Why?
|
Particle Size | 1 | 2004 | 1649 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15721 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1597 | 0.010 |
Why?
|
Compliance | 1 | 1999 | 100 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4138 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2013 | 3976 | 0.010 |
Why?
|
Ventilation | 1 | 1999 | 128 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1838 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16954 | 0.010 |
Why?
|
Quinuclidinyl Benzilate | 1 | 1998 | 19 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 623 | 0.010 |
Why?
|
Citrulline | 1 | 1998 | 107 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4009 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2003 | 607 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 1998 | 157 | 0.010 |
Why?
|
Cathepsin B | 1 | 1997 | 80 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1997 | 366 | 0.010 |
Why?
|
Glass | 1 | 1997 | 115 | 0.010 |
Why?
|
Tritium | 1 | 1997 | 706 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13632 | 0.010 |
Why?
|
Magnetics | 1 | 1999 | 598 | 0.010 |
Why?
|
Calcium Channel Agonists | 1 | 1996 | 26 | 0.010 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1996 | 34 | 0.010 |
Why?
|
Caspase 1 | 1 | 1997 | 226 | 0.010 |
Why?
|
Indazoles | 1 | 1998 | 304 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7386 | 0.010 |
Why?
|
Muscimol | 1 | 1995 | 70 | 0.010 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1995 | 59 | 0.010 |
Why?
|
GABA-A Receptor Agonists | 1 | 1995 | 86 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39127 | 0.010 |
Why?
|
GABA Agonists | 1 | 1995 | 104 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1999 | 1147 | 0.010 |
Why?
|
Baclofen | 1 | 1995 | 120 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3534 | 0.010 |
Why?
|
Capsaicin | 1 | 1995 | 232 | 0.010 |
Why?
|
Administration, Topical | 1 | 1996 | 703 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 1751 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1996 | 1762 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1997 | 1250 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1997 | 941 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12976 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1999 | 1405 | 0.010 |
Why?
|
Ion Channels | 1 | 1996 | 1038 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2008 | 11512 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2011 | 8606 | 0.010 |
Why?
|
Blotting, Western | 1 | 1997 | 5032 | 0.010 |
Why?
|
Disease Progression | 1 | 2003 | 13511 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2006 | 11476 | 0.000 |
Why?
|
Gene Expression | 1 | 1997 | 7571 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15521 | 0.000 |
Why?
|